Bridgewater Associates’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,424
| Closed | -$952K | – | 847 |
|
|
2024
Q3 | $952K | Sell |
16,424
-18,776
| -53% | -$1.09M | 0.01% | 608 |
|
|
2024
Q2 | $1.43M | Sell |
35,200
-3,720
| -10% | -$151K | 0.01% | 597 |
|
|
2024
Q1 | $1.63M | Sell |
38,920
-6,630
| -15% | -$278K | 0.01% | 522 |
|
|
2023
Q4 | $1.74M | Sell |
45,550
-1,963
| -4% | -$75.2K | 0.01% | 539 |
|
|
2023
Q3 | $1.47M | Buy |
47,513
+2,369
| +5% | +$73.1K | 0.01% | 551 |
|
|
2023
Q2 | $1.43M | Sell |
45,144
-5,129
| -10% | -$162K | 0.01% | 523 |
|
|
2023
Q1 | $1.83M | Buy |
50,273
+11,052
| +28% | +$403K | 0.01% | 472 |
|
|
2022
Q4 | $1.16M | Sell |
39,221
-10,291
| -21% | -$305K | 0.01% | 626 |
|
|
2022
Q3 | $1.93M | Sell |
49,512
-90
| -0.2% | -$3.51K | 0.01% | 573 |
|
|
2022
Q2 | $1.91M | Buy |
49,602
+6,454
| +15% | +$249K | 0.01% | 692 |
|
|
2022
Q1 | $2.09M | Buy |
43,148
+10,665
| +33% | +$517K | 0.01% | 675 |
|
|
2021
Q4 | $2.39M | Sell |
32,483
-16,041
| -33% | -$1.18M | 0.01% | 435 |
|
|
2021
Q3 | $4.42M | Buy |
48,524
+4,912
| +11% | +$447K | 0.02% | 306 |
|
|
2021
Q2 | $2.74M | Buy |
+43,612
| New | +$2.74M | 0.02% | 436 |
|